Advertising of first aid creams containing bufexamac to cease in Australia
Australia | News | 0 Comment | 16 Sep, 2020
The Therapeutic Goods Administration (TGA) is reminding advertisers that first aid creams containing bufexamac c...Read more
Genomic leaders to create Australia’s first national COVID-19 tracking system
Australia | News | 0 Comment | 16 Sep, 2020
Illumina has recently announced that the Australian public health laboratories will aim to sequence the virus genomes of...Read more
Australia launches new COVID-19 mental health clinics
Australia | News | 0 Comment | 15 Sep, 2020
The Australian government has announced that Victoria province now will have access to additional mental health support ...Read more
Australia releases digital health skills and training plan
Australia | News | 0 Comment | 14 Sep, 2020
A national digital health skills and training plan has been released to help the Australian health workforce use technol...Read more
Australia inks $3.7 M deal for nasal swab kits
Australia | News | 0 Comment | 11 Sep, 2020
The Australian Government has signed a $3.7 million contract with a Melbourne company to supply sterile nasal swab kits ...Read more
Australia inks $1.7B worth agreement for COVID-19 vaccine
Australia | News | 0 Comment | 08 Sep, 2020
A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successf...Read more
Australia to create a roadmap for health services
Australia | News | 0 Comment | 09 Sep, 2020
Australis's Queensland government project will use the HIMSS Digital Health Indicator to help health workers i...Read more
Australia deals with AstraZeneca for AZD1222 COVID-19 investigational vaccine
Australia | News | 0 Comment | 07 Sep, 2020
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, as a potential candidate for an emergency use authorization (EU...Read more
SpeeDx, Nepean Hospital receive funding for respiratory virus biomarker testing
Australia | News | 0 Comment | 07 Sep, 2020
Innovative molecular diagnostic solution developer SpeeDx Pty. Ltd. based in Sydney has collaborated with researchers in...Read more
Australia to invest $16.9M on health & medical research
Australia | News | 0 Comment | 04 Sep, 2020
The Australian government announced an investment of more than $1 billion in groundbreaking medical research through the...Read more
Bridgewest acquires Pfizer manufacturing facility in Australia
Australia | News | 0 Comment | 03 Sep, 2020
The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation anno...Read more
Australia gives additional funding to reinforce aged care sector
Australia | News | 0 Comment | 02 Sep, 2020
The Australian Government will provide an additional $563.3 million to extend support for the aged care sector’s r...Read more
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Australia | News | 0 Comment | 01 Sep, 2020
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurologic...Read more
Luina Bio announces new bio-manufacturing GMP & development facility expansion
Australia | News | 0 Comment | 01 Sep, 2020
Luina Bio, one of Australia’s most experienced biopharmaceutical contract development and manufacturing (CDMO) org...Read more
Australia brings hope for type 1 diabetes treatment
Australia | News | 1 Comment | 31 Aug, 2020
An international team including the University of Sydney, Australia has reprogrammed human stem cells to generate insuli...Read more
Australia discovers potential new treatment for brain cancer
Australia | News | 0 Comment | 28 Aug, 2020
A recent study by Monash University, Australia has uncovered a potential new drug that may lead to new treatments for co...Read more
Novotech receives "2020 Frost & Sullivan Asia-Pacific CRO Company of the Year’
Australia | News | 0 Comment | 26 Aug, 2020
Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the ‘2020 Frost & Su...Read more
Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years
Australia | News | 0 Comment | 27 Aug, 2020
The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...Read more